Artificial intelligence (AI) has shown excellent diagnostic performance in detecting various complex problems related to many areas of healthcare including ophthalmology. AI …
O Cegielska, M Sierakowski, P Sajkiewicz… - European Journal of …, 2022 - Elsevier
Despite the advances in the field of pharmaceutical materials and technology, topical administration remains a method of choice for the treatment of eye diseases such as …
Glaucoma is the leading cause of irreversible blindness in the world. Due to its potential to cause permanent vision loss, it is important to understand how systemic conditions and their …
F Fang, J Zhang, P Zhuang, P Liu, L Li, H Huang… - Scientific reports, 2021 - nature.com
Recently, we established silicone oil-induced ocular hypertension (SOHU) mouse model with significant glaucomatous neurodegeneration. Here we characterize two additional …
BS Ajgaonkar, A Kumaran, S Kumar, RD Jain… - Stem Cell Reviews and …, 2023 - Springer
Maintenance of the visual function is the desired outcome of ophthalmologic therapies. The shortcomings of the current treatment options, like partial recovery, post-operation failure …
Z Liu, Y Hu, Y Wang, B Xu, J Zhao, Z Yu - Frontiers in Nutrition, 2023 - frontiersin.org
Objective Glaucoma has currently become the second leading cause of blindness in the world. Serum vitamin B12 level has been found to be involved in the development and …
Glaucoma, a leading cause of blindness, damages the optic nerve, making early diagnosis challenging due to no initial symptoms. Fundus eye images taken with a non-mydriatic …
Background: Pathophysiological overlaps exist between diabetes and primary open-angle glaucoma (POAG) and presence of diabetes increases the risk of POAG. Considering that …
Glaucoma is a chronic optic neuropathy characterized by irreversible damage to the retinal nerve fiber layer (RNFL), resulting in changes in the visual field (VC). Glaucoma screening is …